TATVASpecialty Chemicals
Tatva Chintan Pharma Chem Limited — PE Ratio & Valuation Analysis
₹1052.40
-5.07%
Current P/E189.69xPrice to earnings
Industry P/E29.20xSector average
4Y Avg P/E185.1x2.5% above avg
⚠️
549.6% Premium to Industry
TATVA P/E 189.69x vs sector avg 29.20x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹2.44 | ₹1334 | 546.8x |
| 2024 | ₹13.26 | ₹890 | 67.1x |
| 2023 | ₹20.52 | ₹1602 | 78.1x |
| 2022 | ₹44.59 | ₹2151 | 48.2x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Tatva Chintan Pharma Chem Limited Valuation
Tatva Chintan Pharma Chem Limited (TATVA) currently trades at 189.69x earnings. The Specialty Chemicals sector average PE is 29.20x. TATVA commands a premium, reflecting high growth expectations. Historically, TATVA has traded at an average PE of 185.1x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
0.78%
Dividend Yield
0.07%
More on Tatva Chintan Pharma Chem Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.